Save more with Cell KITs - Primary cells and recommended media together at a discounted price.

Explore our products

Choose your region

Stem cell potency: types, differentiation, and applications

Stem cell potency refers to the ability of stem cells to give rise to various cell types. It is an important consideration in regenerative medicine, as stem cells vary in their differentiation potential. Selecting the right stem cell population and culture strategy for a specific application can therefore be challenging. Understanding stem cell potency can help guide these decisions.

What is stem cell potency?

Stem cell potency reflects the developmental potential of a stem cell, or the range of cell types that a stem cell can produce.1 This range narrows during development, largely because specific genes switch on or off inside the cell.2,3 Higher potency means broader gene activity, whereas lower potency means more fixed gene expression programs. Stem cell potency is a snapshot of a cell’s genetic flexibility at a given moment.

What are the different types of stem cell potency?

Stem cell potency follows a hierarchy, ranging from unipotent cells that can generate cells of a single lineage (e.g., an epidermal stem cell that can only give rise to more skin cells) to totipotent cells that can give rise to an entire organism (e.g., a fertilized egg capable of giving rise to an entire organism).1,4 Table 1 provides examples of all the different levels of stem cell potency.

Hierarchy Potency type Differentiation capacity Example
1 (highest) Totipotent All cell types, plus extraembryonic tissue Zygote
2 Pluripotent All body cell types Embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs)
3 Multipotent Multiple related lineages Mesenchymal stem cells (MSCs), hematopoietic stem cells (HSCs)
4 Oligopotent A few related lineages Myeloid progenitor cells, hematopoietic progenitor cells (HPCs)
5 (lowest) Unipotent A single lineage Skin stem cells, fully commited HPCs

Table 1: Hierarchy of stem cell potency1,4

The main difference between potency levels is the number of cell lineages each stem cell can generate.

Totipotent cells exist only in the earliest stages of life, right after fertilization.5 Pluripotent cells, including embryonic stem cells and induced pluripotent stem cells, lose the ability to form a placenta but can still generate nearly every tissue in the body.5 Multipotent cells, such as mesenchymal stem cells (MSCs) and hematopoietic stem cells, further specialize into related cell lineages.6 Oligopotent cells can give rise to only a few related lineages, and unipotent stem cells commit to a single lineage, such as the cells that continuously replace your skin.7

Are stem cell potency and differentiation the same?

No. Stem cell potency and differentiation are related concepts, but they are not the same. Stem cell potency is a cell’s differentiation potential, whereas differentiation is the process by which cells use that potential to generate other cell types.8 Potency is also closely linked to cellular plasticity, or the ability of cells to adopt different identities.

Another key property of stem cells is self-renewal, which refers to their ability to produce identical daughter stem cells while maintaining their potency.9

How does stem cell differentiation relate to potency?

Potency decreases as cells differentiate and become more specialized.1,8 Changes in gene expression contribute to lineage commitment during cell differentiation.2,3 Typically, a pluripotent cell that differentiates into a neuron can no longer differentiate into a muscle cell or blood cell. But in the lab, researchers can induce pluripotency in adult cells by reprogramming them back to an embryonic-like state, creating induced pluripotent stem cells (iPSCs).10 MSCs can differentiate into different lineages depending on their tissue of origin. However, their potency becomes progressively restricted as they commit to specific cell fates.11 Similarly, hematopoietic stem and progenitor cells (HSPCs) differentiate along myeloid or lymphoid lineages, ultimately giving rise to specialized blood and immune cells.12

Figure 1: Lineage potential of mesenchymal stromal cells (MSCs) and CD34+ hematopoietic stem and progenitor cells (HSPCs). (A) MSCs can self-renew and differentiate into multiple cell lineages. (B) CD34+ HSPCs can differentiate along myeloid and lymphoid lineages to generate blood and immune cells.

What regulates stem cell potency and differentiation?

Two categories of signals regulate stemness, including stem cell potency, cell fate, and differentiation.

Intrinsic factors (signals from inside the cell)13,14:

  • Gene expression patterns that switch potency-related genes on or off
  • Epigenetic marks that lock certain genes into an active or silent state

Extrinsic factors (signals from the cell’s environment)15,16:

  • Growth factors and cytokines that signal a cell to specialize
  • The extracellular matrix, oxygen levels, and physical cues from neighboring cells and matrix

Signals from both inside and outside cells influence the sets of genes a given cell expresses, thereby contributing to lineage commitment and cell differentiation.4,17

That’s why cell culture conditions are so important in stem cell research. Suboptimal culture conditions can alter gene expression, reduce stem cell potency, or bias differentiation toward unintended cell lineages. If culture conditions, including culture media, are not optimal for your specific cell type, stem cells can drift toward the wrong cell fate or fail to differentiate.

Why is stem cell potency important in research and therapy?

Stem cell potency sits at the center of regenerative medicine, disease modeling, and drug discovery.18,19 Researchers need to know what stem cells can become and how to induce their differentiation into a specific cell type before using them for research or therapeutic applications.

For example, pluripotent stem cells can generate various cell types and are commonly used in research applications such as organoid development and disease modeling.18,19 Multipotent and oligopotent stem cells, including MSCs and HSPCs, are valuable for translational research and clinical applications.20,21 In fact both cell types have shown significant therapeutic promise across a range of diseases.

What is the therapeutic potential of MSCs and HSPCs

MSCs have shown therapeutic potential in various conditions, largely because of their immunomodulatory and regenerative properties. They are being investigated for graft-versus-host disease, osteoarthritis and cartilage repair, wound healing, and other conditions involving inflammation or tissue damage.22 MSC-derived extracellular vesicles (EVs) are also being explored as delivery vehicles for targeted therapeutics.23 HSPCs are the foundation of hematopoietic stem cell transplantation, restoring blood and immune cell production in patients with leukemia, lymphoma, and other hematologic disorders.24

Despite this promise, realizing the full potential of MSCs and HSPCs depends on maintaining consistent cell quality, robust characterization, and optimized culture conditions. A protocol that works once in a dish doesn’t always work in a bioreactor. Even small batch-to-batch differences can affect differentiation outcomes. Standardized culture systems are critical for generating reproducible and scalable results in both research and translational applications.

Practical tookit: stem cell culture and differentiation solutions

Reliable stem cell research depends on robust potency assessment, optimized culture conditions, and controlled differentiation protocols. Achieving these goals requires high-quality stem cells, properly formulated differentiation inducers, and low-serum, serum-free, or xeno-free growth media.

We support stem cell research by offering:

Browse the full range of stem cell products for cells and media matched to your potency level, including GMP MSC media through the PromoExQ off-the-shelf portfolio.

FAQs

Stem cells can come from embryos (embryonic stem cells), adult tissues such as bone marrow or fat (adult stem cells), and reprogrammed adult cells (induced pluripotent stem cells). Stem cells from different sources have varying levels of potency.1,4,5
Stem cells can divide to produce more stem cells (self-renewal) and can differentiate into specialized cell types (differentiation potential).8 These properties make stem cells key to tissue growth and tissue repair.
No. Stem cell potency varies from totipotent cells, which can build an entire organism, to unipotent stem cells, which can replace only one cell type. Where a cell sits on that scale depends on its origin and developmental stage.1,4
Hematopoietic stem cells are multipotent cells that give rise to blood and immune cells, usually sourced from bone marrow or cord blood.24 Mesenchymal stem cells are also multipotent and differentiate into bone, cartilage, fat, and other connective tissues.25 Both are widely used in stem cell research and stem cell therapies, but for different applications.
Totipotent cells are the most potent. They can give rise to every cell type in the body plus extraembryonic tissues such as the placenta.1,4
Under natural conditions, potency generally decreases as cells differentiate and doesn’t spontaneously return. In the lab, however, researchers can reprogram adult cells back to a pluripotent state, creating induced pluripotent stem cells (iPSCs).10
Cell culture conditions in the lab can shift how stem cells differentiate. Extrinsic signals from the surrounding environment, including growth factors and physical cues, influence stem cell differentiation.13-16
Researchers assess potency using a combination of functional differentiation assays and molecular markers of gene expression associated with different potency states.1
Stemness refers to the core properties that define a stem cell. These include its capacity for self-renewal and its potential to differentiate into other cell types.1,4
Potency describes the range of cell types a stem cell can become, whereas self-renewal describes its ability to divide and produce more stem cells with the same potency.8,9
As development proceeds, gene expression programs and epigenetic marks progressively restrict which genes stay active in a cell, reducing its differentiation options.2,3

References

Expand
  1. Singh VK, Saini A, Kalsan M, Kumar N, Chandra R. (2016). Describing the stem cell potency: the various methods of functional assessment and in silico diagnostics. Front Cell Dev Biol., 4. doi:10.3389/fcell.2016.00134
  2. Biondo M, Cirone N, Valle F, Lazzardi S, Caselle M, Osella M. (2025). The intrinsic dimension of gene expression during cell differentiation. Nucleic Acids Res., 53(16):gkaf805. doi:10.1093/nar/gkaf805
  3. Hemberger M, Dean W, Reik W. (2009). Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington’s canal. Nat Rev Mol Cell Biol., 10(8):526-537. doi:10.1038/nrm2727
  4. Beumer J, Clevers H. (2024). Hallmarks of stemness in mammalian tissues. Cell Stem Cell., 31(1):7-24. doi:10.1016/j.stem.2023.12.006
  5. Du P, Wu J. (2024). Hallmarks of totipotent and pluripotent stem cell states. Cell Stem Cell., 31(3):312-333. doi:10.1016/j.stem.2024.01.009
  6. Aprile D, Patrone D, Peluso G, Galderisi U. (2024). Multipotent/pluripotent stem cell populations in stromal tissues and peripheral blood: exploring diversity, potential, and therapeutic applications. Stem Cell Res Ther., 15(1):139. doi:10.1186/s13287-024-03752-x
  7. Notta F, Zandi S, Takayama N, et al. (2016). Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science., 351(6269):aab2116. doi:10.1126/science.aab2116
  8. Pittenger MF, Kerr CL. (2023). Stem cells. In: Tissue Engineering. Elsevier; 2023:13-69. doi:10.1016/B978-0-12-824459-3.00002-0
  9. Shenghui H, Nakada D, Morrison SJ. (2009). Mechanisms of stem cell self-renewal. Annu Rev Cell Dev Biol., 25(1):377-406. doi:10.1146/annurev.cellbio.042308.113248
  10. Stadtfeld M, Hochedlinger K. (2010). Induced pluripotency: history, mechanisms, and applications. Genes Dev., 24(20):2239-2263. doi:10.1101/gad.1963910
  11. Robey PG. (2017). “Mesenchymal stem cells”: fact or fiction, and implications in their therapeutic use. F1000Research., 6:524. doi:10.12688/f1000research.10955.1
  12. Weiskopf K, Schnorr PJ, Pang WW, et al. (2016). Myeloid cell origins, differentiation, and clinical implications. Gordon S, ed. Microbiol Spectr., 4(5):4.5.21. doi:10.1128/microbiolspec.MCHD-0031-2016
  13. Coskun V, Tsoa R, Sun YE. (2012). Epigenetic regulation of stem cells differentiating along the neural lineage. Curr Opin Neurobiol., 22(5):762-767. doi:10.1016/j.conb.2012.07.001
  14. Perez-Campo F, Riancho J. (2015). Epigenetic mechanisms regulating mesenchymal stem cell differentiation. Curr Genomics., 16(6):368-383. doi:10.2174/1389202916666150817202559
  15. Discher DE, Mooney DJ, Zandstra PW. (2009). Growth factors, matrices, and forces combine and control stem cells. Science., 324(5935):1673-1677. doi:10.1126/science.1171643
  16. Zhao T, Huang Y, Zhu J, et al. (2025). Extracellular matrix signaling cues: biological functions, diseases, and therapeutic targets. MedComm., 6(8):e70281. doi:10.1002/mco2.70281
  17. Enver T, Pera M, Peterson C, Andrews PW. (2009). Stem cell states, fates, and the rules of attraction. Cell Stem Cell., 4(5):387-397. doi:10.1016/j.stem.2009.04.011
  18. Singh VK, Kalsan M, Kumar N, Saini A, Chandra R. (2015). Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol., 3. doi:10.3389/fcell.2015.00002
  19. O’Connor KC, Stanley HJ, Bunnell BA, De Caro R. (2025). Editorial: Role of induced pluripotent stem cells (iPSCs) in regenerative medicine, disease modeling and drug discovery. Front Bioeng Biotechnol., 13:1734717. doi:10.3389/fbioe.2025.1734717
  20. Zhao X, Ming X, Wu J, Zhu X, Xiao Y. (2026). Mesenchymal stromal cells: bridging the gaps in hematologic disease therapy. Stem Cell Rev Rep., 22(1):434-488. doi:10.1007/s12015-025-11011-6
  21. Bujko K, Kucia M, Ratajczak J, Ratajczak MZ. (2019). Hematopoietic stem and progenitor cells (HSPCs). In: Ratajczak MZ, ed. Stem Cells. Vol 1201. Advances in Experimental Medicine and Biology. Springer International Publishing; 2019:49-77. doi:10.1007/978-3-030-31206-0_3
  22. Wu X, Jiang J, Gu Z, Zhang J, Chen Y, Liu X. (2020). Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress. Stem Cell Res Ther., 11(1):345. doi:10.1186/s13287-020-01855-9
  23. Shi J, Zhao YC, Niu ZF, et al. (2021). Mesenchymal stem cell-derived small extracellular vesicles in the treatment of human diseases: Progress and prospect. World J Stem Cells., 13(1):49-63. doi:10.4252/wjsc.v13.i1.49
  24. Lee JY, Hong SH. (2019). Hematopoietic stem cells and their roles in tissue regeneration. Int J Stem Cells., 13(1):1-12. doi:10.15283/ijsc19127
  25. Han X, Liao R, Li X, et al. (2025). Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther., 10(1):262. doi:10.1038/s41392-025-02313-9

PromoCell uses HubSpot to provide LiveChat support. This feature is currently blocked due to your cookie preferences.

Accept cookies to enable LiveChat